Kronox Lab Sciences reported a net profit of ₹730.3 lakh for the quarter ended June 30, 2026, an increase of 16% compared to ₹627.9 lakh in the same period of the previous fiscal year. Revenue from operations rose 17% year-on-year to ₹2,838.6 lakh, up from ₹2,428.7 lakh in Q1FY26.

The Vadodara-based specialty fine chemical manufacturer saw its profit before tax climb to ₹981.0 lakh from ₹844.1 lakh in the prior year quarter. This growth was underpinned by higher operational activity, reflected in increased cost of materials consumed, which rose to ₹1,509.3 lakh from ₹1,287.2 lakh year-on-year.

Financial Highlights

Earnings per share stood at ₹2.0, compared to ₹1.7 in the corresponding quarter of FY26. Other income declined to ₹129.7 lakh from ₹214.6 lakh in the previous quarter but remained above the ₹87.3 lakh recorded in Q1FY26.

What the Numbers Show

The company’s top-line growth outpaced the rise in total expenses, resulting in an expansion of pre-tax margins. While revenue grew nearly 17%, total expenses increased by approximately 19%, primarily driven by a rise in cost of materials consumed and other expenses, which jumped to ₹347.6 lakh from ₹277.9 lakh year-on-year. Despite this pressure on costs, net profit maintained a robust growth trajectory, indicating effective management of operational leverage amidst higher input costs.

Corporate Actions

The Board of Directors, in its meeting held on August 12, 2026, approved the unaudited standalone financial results for the quarter ended June 30, 2026. The results were reviewed by statutory auditors Mahesh Udhwani & Associates.

Key decisions included:

• Convening the 17th Annual General Meeting (AGM) on September 16, 2026.
• Closure of the Register of Members and Share Transfer Books from September 10, 2026, to September 16, 2026, to determine eligibility for the final dividend, if declared.
• Re-appointment of M/s. Jaimin & Associates as Internal Auditors for the financial year 2026-27.
• Appointment of M/s. Diwanji & Associates as Cost Auditors for the financial year 2026-27.

Kronox Lab Sciences Limited has announced its audited standalone financial results for the quarter and year ended March 31, 2026. The company reported a net profit of ₹800.21 lakh for the quarter ended March 31, 2026, compared to ₹631.52 lakh in the corresponding quarter of the previous year. For the full financial year, the net profit stood at ₹2,766.00 lakh, an increase from ₹2,546.70 lakh in FY25.

Financial Performance

The revenue from operations for the year ended March 31, 2026, was ₹10,122.00 lakh, compared to ₹10,019.40 lakh in the previous year. Total income for the year rose to ₹10,641.40 lakh from ₹10,272.00 lakh in the prior year. The company's earnings per share (EPS) for the year increased to ₹7.51 from ₹6.91 in the previous year.

Dividend Declaration

The Board of Directors has recommended a final dividend of 5%, which translates to ₹0.50 per equity share of ₹10 each, for the financial year 2025-26. This dividend is subject to the approval of shareholders.

Regulatory Compliance

Pursuant to Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the company published the audited financial results in newspapers on May 23, 2026. The results were reviewed by the auditors, recommended by the Audit Committee, and approved by the Board in its meeting held on May 21, 2026. The statutory auditors, M/s. Mahesh Udhwani & Associates, issued an audit report with an unmodified opinion.